Take this quick quiz to test your knowledge of recent advances most likely to have an impact on weight management in your practice.
Treatments for patients with obesity are in development across the pharmaceutical industry, including molecules with novel mechanisms of action that have been evaluated in clinical trials but have not yet received FDA approval.
Take this quick quiz to test your knowledge of the recent advances most likely to have an impact on weight management in your practice.
Obesity Linked to Faster Alzheimer Disease Progression in Longitudinal Blood Biomarker Analysis
December 2nd 2025Biomarker trajectories over 5 years in study participants with AD show steeper rises in pTau217, NfL, and amyloid burden among those with obesity, highlighting risk factor relevance.